ABAmy C. Brook

Amy C. Brook

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Amy C. Brook has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Matthias Eberl

    Division of Infection and Immunity, School of Medicine Cardiff University Cardiff UK

    3 shared publications
  • Donald J. Fraser

    Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom

    2 shared publications
  • Timothy Bowen

    Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom

    2 shared publications
  • Aled Clayton

    Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom

    1 shared publication
  • Alex P. Shephard

    Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom

    1 shared publication
  • Ann Kift-Morgan

    Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom

    1 shared publication

Latest Publications

  • Open Access

    Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis

    by Amy C. Brook, Robert H. Jenkins, Aled Clayton, Ann Kift-Morgan, Anne-Catherine Raby, Alex P. Shephard, Barbara Mariotti, Simone M. Cuff, Flavia Bazzoni, Timothy Bowen, et al.

    Infection remains a major cause of morbidity, mortality and technique failure in patients with end stage kidney failure who receive peritoneal dialysis (PD). Recent research suggests that the early inflammatory response at the site of infection carries diagnostically relevant information, suggesting that organ and pathogen-specific “immune fingerprints” may guide targeted treatment decisions and allow patient stratification and risk prediction at the point of care. Here, we recorded microRNA profiles in the PD effluent of patients presenting with symptoms of acute peritonitis and show that elevated peritoneal miR-223 and reduced miR-31 levels were useful predictors of bacterial infection. Cell culture experiments indicated that miR-223 was predominantly produced by infiltrating immune cells (neutrophils, monocytes), while miR-31 was mainly derived from the local tissue (mesothelial cells, fibroblasts). miR-223 was found to be functionally stabilised in PD effluent from peritonitis patients, with a proportion likely to be incorporated into neutrophil-derived exosomes. Our study demonstrates that microRNAs are useful biomarkers of bacterial infection in PD-related peritonitis and have the potential to contribute to disease-specific immune fingerprints. Exosome-encapsulated microRNAs may have a functional role in intercellular communication between immune cells responding to the infection and the local tissue, to help clear the infection, resolve the inflammation and restore homeostasis.


  • Open Access

    Analysis of the Ribonuclease A Superfamily of Antimicrobial Peptides in Patients Undergoing Chronic Peritoneal Dialysis

    by Neha Dhingra Pottanat, Amy C. Brook, Maria Bartosova, Hanna Cortado, Sudipti Gupta, Birong Li, Ashley R. Jackson, Martin Vonau, Shira Cohen, Maria Ferrara, et al.

    Infectious peritonitis is a common complication in patients undergoing chronic peritoneal dialysis (PD), limiting the duration of PD as a modality for renal replacement therapy and increasing patient morbidity and mortality. Antimicrobial peptides (AMPs) serve critical roles in mucosal defense, but their expression and activity during peritonitis are poorly understood. We hypothesized that AMPs belonging to the Ribonuclease (RNase) A Superfamily are present in peritoneal fluid and increase during peritonitis in patients undergoing chronic PD. In the absence of peritonitis, we detected RNase 3, RNase 6, and RNase 7 in cell-free supernatants and viable cells obtained from peritoneal fluid of chronic PD patients. The cellular sources of these RNases were eosinophils (RNase 3), macrophages (RNase 6), and mesothelial cells (RNase 7). During peritonitis, RNase 3 increased 55-fold and RNase 7 levels increased 3-fold on average, whereas RNase 6 levels were unchanged. The areas under the receiver-operating characteristic curves for RNase 3 and RNase 7 were 0.99 (95% confidence interval (CI): 0.96–1.0) and 0.79 (95% CI: 0.64–0.93), respectively, indicating their potential as biomarkers of peritonitis. Discrete omental reservoirs of these RNases were evident in patients with end stage kidney disease prior to PD initiation, and omental RNase 3 reactive cells increased in patients undergoing PD with a history of peritonitis. We propose that constitutive and inducible pools of antimicrobial RNases form a network to shield the peritoneal cavity from microbial invasion in patients undergoing chronic PD.


  • Open Access

    Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial Ligands and Induce Local Tissue Remodeling

    by Anna Rita Liuzzi, Ann Kift-Morgan, Melisa Lopez-Anton, Ida M. Friberg, Jingjing Zhang, Amy C. Brook, Gareth W. Roberts, Kieron L. Donovan, Chantal S. Colmont, Mark A Toleman, et al.

    The antimicrobial responsiveness and function of unconventional human T cells are poorly understood, with only limited access to relevant specimens from sites of infection. Peritonitis is a common and serious complication in individuals with end-stage kidney disease receiving peritoneal dialysis. By analyzing local and systemic immune responses in peritoneal dialysis patients presenting with acute bacterial peritonitis and monitoring individuals before and during defined infectious episodes, our data show that Vγ9/Vδ2+ γδ T cells and mucosal-associated invariant T cells accumulate at the site of infection with organisms producing (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate and vitamin B2, respectively. Such unconventional human T cells are major producers of IFN-γ and TNF-α in response to these ligands that are shared by many microbial pathogens and affect the cells lining the peritoneal cavity by triggering local inflammation and inducing tissue remodeling with consequences for peritoneal membrane integrity. Our data uncover a crucial role for Vγ9/Vδ2 T cells and mucosal-associated invariant T cells in bacterial infection and suggest that they represent a useful predictive marker for important clinical outcomes, which may inform future stratification and patient management. These findings are likely to be applicable to other acute infections where local activation of unconventional T cells contributes to the antimicrobial inflammatory response.